Less invasive surfactant timing with different pre-medications
Part of Lungs & breathing clinical trials.
This study tests whether giving a pre-medication before a less invasive lung treatment (surfactant) improves breathing in premature babies. It may help some babies avoid more invasive ventilation while still getting the lung medication they need.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Baby was born at 26 weeks of pregnancy or later
- Baby is having breathing trouble but is managed without a breathing tube, using support like nasal CPAP or high-flow
- Baby needs extra oxygen to keep oxygen levels in the target range
- A clinician thinks the baby needs surfactant treatment (a lung medicine)
- If the baby needs more surfactant doses, they can be re-assigned to the study group again
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a less invasive way to give surfactant (a lung treatment) to babies born a few weeks early who need breathing help. It aims to see if this method works as well as standard care.
This trial tests two ways of giving surfactant (a lung medicine) to very premature babies with respiratory distress syndrome. It may help show which method works better and is safer for helping newborn lungs breathe.
This study compares two methods—video laryngoscopy and direct laryngoscopy—to give surfactant (a medicine that helps babies' lungs work better) to very premature infants. It aims to find which method is safer and easier for babies born at 28 weeks or earlier who need surfactant within the first 36 hours after birth.
This trial tests whether giving surfactant (a substance that helps lungs stay open) to premature babies with Respiratory Distress Syndrome (RDS) through a mask on the throat (supraglottic airway) is safe and effective. It may be an option for babies who need extra oxygen but are not on a breathing tube.
This study tests a lung medication called pulmonary surfactant, given with different oxygen levels, to help very premature babies (born before 32 weeks) who have breathing difficulties. The goal is to see which oxygen level works best with non-invasive breathing support.
This trial compares two types of surfactant (Calfactant and Poractant Alfa) given through a less invasive method to very premature babies with breathing problems. It aims to see if one works better at helping them breathe without needing a breathing tube.
Hear when a new Surfactant Deficiency Syndrome Neonatal trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.